EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Clinical Features Associated with Chronic Lung Allograft Dysfunction Progression in a Multicenter Cohort

Jamie L Todd iD, Megan L Neely iD, Jesse Y Hsu iD, Joshua M Diamond, Michaela R Anderson, Edward Cantu, Emily Clausen, Krishna Pandya, Michelle Oyster, Laurel Kalman, Courtney W Frankel, Luke Benvenuto und 9 weitere

American Journal of Respiratory and Critical Care Medicine · 2026

DOI: 10.1093/ajrccm/aamaf055 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Respiratory and Critical Care Medicine, 2026. Verfasst von Jamie L Todd und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, United States. Hauptthemen laut MEDLINE: Lung Transplantation, Primary Graft Dysfunction, Graft Rejection. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Clinical features that impact outcomes in lung recipients with chronic lung allograft dysfunction (CLAD) are uncertain and limited by existing approaches to phenotyping that rely on measures inconsistently performed or not standardized across centers.

Objective

We used data from the prospective multicenter Lung Transplant Outcomes Group (LTOG) cohort study to determine if routine, objective clinical measures at CLAD diagnosis impact progression to graft loss (death/retransplantation).

Methods

The analysis included 2386 adult lung recipients from 9 US centers. Probable CLAD was defined according to International Society for Heart and Lung Transplantation criteria. Cox models were fit for time from probable CLAD to graft loss as a function of each clinical feature of interest including CLAD stage (1–4), CLAD timing (early-onset, <2 years posttransplant), FVC loss (FVCCLAD/FVCBest <0.8), and FEV1/FVC ratio <0.7. Models included a random effect for center and were adjusted for recipient age, sex, transplant type, and native lung disease. Measurements and Main Results Probable CLAD developed in 1418 patients (59.4%). At onset, 80.7% had stage 1 CLAD, 41.3% had early-onset CLAD, 35.8% had FVC loss, and 46.5% had an FEV1/FVC ratio <0.7. In adjusted analyses, patients with CLAD stage ≥2, early-onset CLAD, and FVC loss had significantly higher hazards for graft loss, while FEV1/FVC <0.7 was associated with reduced graft loss risk.

Conclusions

We provide compelling evidence that routine, objective measures at CLAD onset inform CLAD progression risk. Such stratification of disease behavior is important to patient prognostication and may inform the design of future CLAD trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationPrimary Graft DysfunctionGraft RejectionHumansFemaleMaleDisease ProgressionMiddle AgedProspective StudiesAdultChronic DiseaseAllograftsCohort StudiesUnited States

Stichwörter der Autor:innen

chronic lung allograft dysfunctionchronic lung allograft dysfunction progressiongraft losslung transplant

Autor:innen und Institutionen

  • Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, United States.
  • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, United States.
  • Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States.
  • Department of Biostatistics, Epidemiology & Informatics, University of Pennsylvania, Philadelphia, PA, United States.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Department of Surgery, University of Pennsylvania, Philadelphia, PA, United States.

ORCID-Profile: Jamie L Todd, Megan L Neely, Jesse Y Hsu, Jonathan P Singer

Förderung

  • NIAID NIH HHS
  • NIH HHS

Zitieren

APA

Todd, J. L., Neely, M. L., Hsu, J. Y., Diamond, J. M., Anderson, M. R., Cantu, E., Clausen, E., Pandya, K., Oyster, M., Kalman, L., Frankel, C. W., Benvenuto, L., Combs, M., Dhillon, G., McDyer, J., Patel, M., Shah, P. D., Singer, J. P., Snyder, L. D., …, & Palmer, S. M. (2026). Clinical Features Associated with Chronic Lung Allograft Dysfunction Progression in a Multicenter Cohort. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1093/ajrccm/aamaf055

Vancouver

Todd JL, Neely ML, Hsu JY, Diamond JM, Anderson MR, Cantu E, et al. Clinical Features Associated with Chronic Lung Allograft Dysfunction Progression in a Multicenter Cohort. American Journal of Respiratory and Critical Care Medicine. 2026. doi:10.1093/ajrccm/aamaf055

BibTeX
@article{Todd2026,
  author = {Todd, Jamie L and Neely, Megan L and Hsu, Jesse Y and Diamond, Joshua M and Anderson, Michaela R and Cantu, Edward and Clausen, Emily and Pandya, Krishna and Oyster, Michelle and Kalman, Laurel and Frankel, Courtney W and Benvenuto, Luke and Combs, Michael and Dhillon, Gundeep and McDyer, John and Patel, Mrunal and Shah, Pali D and Singer, Jonathan P and Snyder, Laurie D and Christie, Jason D and Palmer, Scott M},
  title = {Clinical Features Associated with Chronic Lung Allograft Dysfunction Progression in a Multicenter Cohort},
  journal = {American Journal of Respiratory and Critical Care Medicine},
  year = {2026},
  doi = {10.1093/ajrccm/aamaf055}
}
Kostenlos starten →